Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Carmeda Coated Stent CE-Marked by Cordis; Carmeda Coating Now Used On Medical Devices Worldwide for Babies, Boomers and the Elderly.


Business Editors & Health/Medical Writers

BIOWIRE2K

SAN ANTONIO--(BW HealthWire)--June 26, 2000

Cordis, a Johnson and Johnson company, announced CE-marking of the Bx Velocity coronary stent coronary stent Intracoronary stent Cardiology An expandable tubular device which can be inserted percutaneously, and left within a coronary artery lumen to maintain its patency Pros Clinical and angiographic outcomes are better with intracoronary artery stent  with the Carmeda coating (May 31, 2000).

A Cordis stent with Carmeda coating also was approved for sale in the U.S. in February, 2000. Cordis joins several other prominent medical device companies which utilize the Carmeda BioActive Surface (CBAS CBAS Command Budget Automated System
CBAS Computrols Building Automation System (building automation software)
CBAS Computerized Building Automation System
CBAS Corporate Business Applications Support
) technology, companies including Medtronic, Gore, Diametrics and Pharmacia.

CBAS is a proprietary heparin coating which retains thromboresistant properties for periods lasting several months. This long-term bioactivity bi·o·ac·tiv·i·ty
n.
The effect of a given agent, such as a vaccine, upon a living organism or on living tissue.
, coupled with the fact that the stable heparin coating does not leave the device surface, differentiates CBAS from other coatings designed to improve the hemocompatibility of blood-contacting devices.

"The market launch of the CBAS-coated stent from Cordis reinforces Carmeda's position as the leader in the hemocompatibility coating market," states Andrew Jacobson, Director of Business Development at Carmeda.

The Carmeda coating technology is applied to medical devices for use in babies, adolescents, baby boomers and the elderly. Diametrics coats blood gas sensors used to monitor premature newborns. Adolescents benefit from Carmeda's blood sampling catheter which is used in growth hormone growth hormone or somatotropin (sōmăt'ətrō`pən), glycoprotein hormone released by the anterior pituitary gland that is necessary for normal skeletal growth in humans (see protein).  studies. Adults are permanently implanted with Carmeda-coated coronary stents from Cordis and undergo heart bypass surgery with the help of Carmeda-coated blood oxygenators from Medtronic. And the elderly receive intraocular lens implants coated with Carmeda-based technology by Pharmacia.

CBAS is the most prevalent and clinically proven thromboresistant coating applied to medical devices by U.S. and European device manufacturers. Since 1985 Carmeda has commercialized the "end-point attachment" of immobilized heparin molecules to medical device surfaces.

Carmeda AB (Stockholm) is majority owned by Norsk Hydro ASA Asa (ā`sə), in the Bible, king of Judah, son and successor of Abijah. He was a good king, zealous in his extirpation of idols. When Baasha of Israel took Ramah (a few miles N of Jerusalem), Asa bought the help of Benhadad of Damascus and  (ADR ADR - Astra Digital Radio ) (NYSE NYSE

See: New York Stock Exchange
:HYDRO). For additional information please visit www.carmeda.com.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 26, 2000
Words:288
Previous Article:REMINDER/Blueprint: Business Strategy Summit for Internet Companies.
Next Article:MerchantOnline.com Selects MS&L for Public Relations and Investor Relations.



Related Articles
Carmeda Coating Approved By FDA For Use On Cordis Bx Velocity Stent; Carmeda Technology Now Available On Several Critical Devices.
Gene therapy might keep arteries open.
Things just mesh: making stents even better at keeping arteries open.
Carmeda Coating On GORE-TEX PROPATEN Vascular Graft Recently Launched in Europe.
Central Venous Catheters Benefit From Carmeda Surface Coating After 30 Days According to Recently Published In-Vivo Data.
Carmeda AB Announces Year-To-Date 2002 Earnings and Revenues.
Berlin Heart INCOR Implanted Blood Pump with Carmeda Coating Receives CE Mark.
Coated inserts keep vessels unclogged.
Berlin Heart INCOR VAD with Carmeda Coating Supports Patient for 520 Days.
Stent repair: coated replacements better than radiation.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles